| Summary of Stock Options Outstanding under Plans |
The table below provides stock option information for the three months ended June 30, 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares |
|
Weighted-
Average
Exercise
Price Per
Share |
|
Weighted-
Average
Remaining
Contractual
Life |
|
Aggregate
Intrinsic
Value of
In-the-
Money
Options |
|
|
|
|
|
|
|
|
(in thousands) |
|
Options outstanding at beginning of period |
337,688 |
|
|
$ |
17.53 |
|
|
4.6 years |
|
$ |
1,356 |
|
(1) |
Options exercised |
(1,250 |
) |
|
$ |
10.80 |
|
|
0.0 years |
|
— |
|
|
Options outstanding at end of period |
336,438 |
|
|
$ |
17.55 |
|
|
4.4 years |
|
$ |
1,162 |
|
(2) |
|
|
|
|
|
|
|
|
|
Options exercisable at end of period |
336,438 |
|
|
$ |
17.55 |
|
|
4.4 years |
|
$ |
1,162 |
|
(2) |
|
|
(1) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $21.27 as of March 31, 2019, over the exercise price, multiplied by the number of options.
|
|
|
(2) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $22.27 as of June 30, 2019, over the exercise price, multiplied by the number of options.
|
The table below provides stock option information for the six months ended June 30, 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares |
|
Weighted-
Average
Exercise
Price Per
Share |
|
Weighted-
Average
Remaining
Contractual
Life |
|
Aggregate
Intrinsic
Value of
In-the-
Money
Options |
|
|
|
|
|
|
|
|
(in thousands) |
|
Options outstanding at beginning of period |
338,338 |
|
|
$ |
17.52 |
|
|
4.6 years |
|
$ |
1,356 |
|
(1) |
Options exercised |
(1,900 |
) |
|
$ |
11.40 |
|
|
1.0 year |
|
18 |
|
|
Options outstanding at end of period |
336,438 |
|
|
$ |
17.55 |
|
|
4.4 years |
|
$ |
1,162 |
|
(2) |
|
|
|
|
|
|
|
|
|
Options exercisable at end of period |
336,438 |
|
|
$ |
17.55 |
|
|
4.4 years |
|
$ |
1,162 |
|
(2) |
|
|
(1) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $19.70 as of December 31, 2018, over the exercise price, multiplied by the number of options.
|
(2)
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $22.27 as of June 30, 2019, over the exercise price, multiplied by the number of options.
|
| Schedule of Restricted Stock Awards |
The table below provides information for restricted stock awards for the period indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, 2019 |
|
Six Months Ended June 30, 2019 |
|
Number of
Shares |
|
Weighted-
Average
Grant Date
Fair Value
Per Share |
|
Number of
Shares
|
|
Weighted-
Average
Grant Date
Fair Value
Per Share
|
Restricted stock at beginning of period |
186,294 |
|
|
$ |
22.31 |
|
|
304,595 |
|
|
$ |
21.98 |
|
Restricted stock granted |
150,025 |
|
|
$ |
22.20 |
|
|
151,695 |
|
|
22.18 |
|
Restricted stock vested |
(16,789 |
) |
|
$ |
28.50 |
|
|
(85,959 |
) |
|
28.09 |
|
Restricted stock forfeited |
(33,331 |
) |
|
$ |
10.91 |
|
|
(84,132 |
) |
|
11.56 |
|
Restricted stock at end of period |
286,199 |
|
|
$ |
23.19 |
|
|
286,199 |
|
|
23.19 |
|
|